Zobrazeno 1 - 10 of 64 pro vyhledávání: '"Pc Waller"'
1
Effects of atenolol withdrawal in patients on triple antihypertensive therapy
Autor: Eg, Bevan, Sd, Pringle, Pc, Waller, Al, Herrick, Jg, Findlay, Gordon Murray, Ha, Carmichael, Ar, Lorimer, Jl, Reid, Rj, Weir
Publikováno v: Europe PubMed Central
The objective of this study was to examine the contribution of beta-blockade to antihypertensive treatment regimens including an angiotensin converting enzyme inhibitor or a calcium antagonist. The effects on BP control, adverse events, and plasma ac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ef9b0e3821b1bf02163393404cc341c3
https://pubmed.ncbi.nlm.nih.gov/8450527
Zobrazit plný text záznamu
5
Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patients
Autor: Eg, Bevan, Sd, Pringle, Pc, Waller, Al, Herrick, Jg, Findlay, Gordon Murray, Ha, Carmichael, Jl, Reid, Rj, Weir, Ar, Lorimer
Publikováno v: Europe PubMed Central
The antihypertensive, biochemical and adverse effects of captopril, hydralazine, nifedipine and placebo were compared in 160 patients with BP inadequately controlled by atenolol 100 mg daily plus bendrofluazide 5 mg daily. Treatments were given for u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af789a0fb71dcb66fc7c9f7c2df1f7c7
http://europepmc.org/abstract/med/8095558
Zobrazit plný text záznamu
10
Akademický článek
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.
Autor: Cooper AJ; GlaxoSmithKline (GSK) Ltd, Greenford, Middlesex, UK. andrew.j.cooper@gsk.com, Lettis S, Chapman CL, Evans SJ, Waller PC, Shakir S, Payvandi N, Murray AB
Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2008 May; Vol. 17 (5), pp. 445-54.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje